期刊文献+

结缔组织生长因子在腹膜纤维化中的作用与调控

Effect and Regulation of Connective Tissue Growth Factor on Peritoneal Fibrosis
下载PDF
导出
摘要 腹膜纤维化已逐渐成为维持性腹膜透析患者退出的主要原因,其发生是有多种因素参与的复杂过程。而结缔组织生长因子作为促纤维化刺激的共同下游介质在这一病理生理过程中发挥了重要作用,被认为可能是较理想的抗腹膜纤维化的靶目标。本文就非生理性腹透液致腹膜纤维化的机制、结缔组织生长因子的生物学特性以及结缔组织生长因子在腹膜纤维化发生过程中的具体作用和调控予以综述。 Peritoneal fibrosis has gradually become the main reason for the withdrawal of maintenance peritoneal dialysis patients. Peritoneal fibrosis is a complicated process controlled by various factors. Connective tissue growth factor ( CTGF), a common downstream mediator of the promoting fibrosis stimulators, has played important effect in this pathophysiological process. Moreover, CTGF is considered to be a better target to prevent peritoneal fibrosis. In this paper, the mechanism of peritoneal fibrosis caused by non-physiologic peritoneal dialysis solutions, the biological characteristics of CTGF, and the effect and regulation of CTGF in the process of peritoneal fibrosis are reviewed.
作者 易斌 刘伏友
出处 《医学综述》 2008年第23期3592-3595,共4页 Medical Recapitulate
关键词 腹膜纤维化 结缔组织生长园子 腹膜间皮细胞 Peritoneal fibrosis Connective tissue growth factor: Peritoneal mesothelial cells
  • 相关文献

参考文献2

二级参考文献13

  • 1David R. Brigstock.Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61)[J].Angiogenesis.2002(3)
  • 2Zhang H,Liu FY,Liu YH.Effect of TGF-betal stimulation on the smad signal transduction pathway of human peritoneal mesothelial cells[].J Cent South Univ(Med Sci).2004
  • 3Offner FA,Feichtinger H,Stadlmann S,Obrist P,Marth C,Klingler P,et al.Transforming growth factor-beta synthesis by human peritoneal mesothelial cells.Induction by interleukin-1[].American Journal of Pathology.1996
  • 4Wang T,Ghen Y G,Ye R G,et al.Enhanced expression of TGF-beta 1 by peritoneal macrophages in CAPD patients[].Advances in Peritoneal Dialysis.1995
  • 5Krediet,RT,Zweers,MM,van der,Wal,AC,Struijk,DG.Neoangiogenesis in the peritoneal membrane[].Peritoneal Dialysis International.2000
  • 6GUNAL AI,CELIKER H,AKPOLAT N,et al.By reducing production of vascular endothelial growth factor octreotide i m-proves the peritoneal vascular alteralations induced by hyper-tonic peritoneal dialysis solution[].Peritoneal Dialysis International.2002
  • 7Motomura,Y,Kanbayashi,H,Khan,WI,Deng,Y,Blennerhassett,PA,Margetts,PJ,Gauldie,J,Egashira,K,Collins,SM.The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-beta type II receptor gene transfer[].American Journal of Physiology Gastrointestinal and Liver Physiology.2005
  • 8Yoshio,Y.,Miyazaki,M.,Abe,K.,Nishino,T.,Furusu,A.,Mizuta,Y.,Harada,T.,Ozono,Y.,Koji,T.,Kohno,S.TNP-470, an angiogenesis inhibitor, suppresses the progression of peritoneal fibrosis in mouse experimental model[].Kidney International.2004
  • 9Inoki,I,Shiomi,T,Hashimoto,G,Enomoto,H,Nakamura,H,Makino,K,Ikeda,E,Takata,S,Kobayashi,K,Okada,Y.Connective tissue growth factor binds vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis[].The FASEB Journal.2002
  • 10Beavis,MJ,Williams,JD,Hoppe,J,Topley,N.Human peritoneal fibroblast proliferation in 3-dimensional culture: modulation by cytokines, growth factors and peritoneal dialysis effluent[].Kidney International.1997

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部